Ambassador Vermuelen (Belgium): introduced the topic and the history of Belgium’s involvement including last year’s initiative, which was at the heart of Belgium’s Presidency of CND. Speakers: Dilkushi Poovendran (WHO), Ghislain D’Hoop, Carolyn Patterson (Assistant Secy Govt of Australia, Health and Aged Care) Jagit Pavadia, President, INCB: Thank you to the govt of Belgium and …
International Narcotics Control Board (INCB)
Side event. Innovation responses to promoting access to controlled medicines, while preventing diversion and non-medical use: Following up on the global “access and availability” campaign led by the chair of the 65th CND
Organised by Belgium with the support of Australia, Austria, Bulgaria, Croatia, Cyprus, Czechia, Denmark, El Salvador, Estonia, Finland, France, Germany, Ghana, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, the United States, the European Union, the UNODC Prevention, Treatment and Rehabilitation Section, the …
Informal Civil Society Dialogue with the INCB President
Moderator: Penny Hill, Vienna NGO Committee on Drugs Speaker: Jagjit Pavadia, INCB President Jagjit Pavadia, INCB President: I am please to meet with you today. The board recognises the important role played by civil society in recognising health and wellbeing. INCB is committed to ongoing cooperation with NGOs including this informal dialogue, meetings during the …
Plenary Item 5. Implementation of the international drug control treaties
Plenary Item 5a Chair: Excellencies, distinguished representatives. Ladies and gentlemen, good morning, I would like to start Agenda Item five, implementation of international drug control treaties. Secretariat: Thank you very much, Mr. Chair, and good morning to all. The commission has before it the Agenda Item 5a: changes in the scope of control of substances. …
CND Chair one-day special forum on availability and access to controlled substances for medical and scientific purposes
Chair: I welcome our panelists. We all know how severe this issue is – medicines are unavailable or unaffordable. This is for a variety of reasons, some of it is regulatory – lets not forget that there is a lot of weork done to optimize legislation. There is also often a lack of professional knowledge. …
CND thematic sessions on the implementation of all international drug policy commitments, following-up to the 2019 Ministerial Declaration – 21 September 2022
Multiyear Workplan 2019-2023: Implementation of all our international drug policy commitments, following up to the 2019 ministerial declaration “Strengthening Our Actions at the National, Regional and International Levels to Accelerate the Implementation of our Joint Commitments to Address and Counter the World Drug Problem” The provisional agenda for the intersessional meeting is as follows: 1. Thematic …